Samarth Kulkarni
Chief Executive Officer bei CRISPR THERAPEUTICS AG
Vermögen: 28 Mio $ am 31.03.2024
Profil
Samarth Kulkarni ist Vorsitzender von Casebia Therapeutics LLP. Dr. Kulkarni ist auch im Vorstand von Black Diamond Therapeutics, Inc. und Repare Therapeutics, Inc. sowie Centessa Pharmaceuticals Ltd. und Chief Executive Officer & Director bei CRISPR Therapeutics AG und Director-Emerging Companies Section bei Biotechnology Innovation Organization. In der Vergangenheit war Samarth Kulkarni als Partner bei McKinsey & Co, Inc. tätig. Er promovierte an der University of Washington und erwarb einen Bachelor-Abschluss am Indian Institute of Technology New Delhi.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CRISPR THERAPEUTICS AG
0,48% | 15.04.2024 | 408 122 ( 0,48% ) | 28 Mio $ | 31.03.2024 |
22.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 | |
16.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 | |
REPARE THERAPEUTICS INC.
-.--% | 08.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Samarth Kulkarni
Unternehmen | Position | Beginn |
---|---|---|
CRISPR THERAPEUTICS AG | Chief Executive Officer | 01.12.2017 |
REPARE THERAPEUTICS INC. | Director/Board Member | 01.11.2019 |
BLACK DIAMOND THERAPEUTICS, INC. | Director/Board Member | 01.12.2019 |
CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 23.02.2021 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | - |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The private company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Samarth Kulkarni
Unternehmen | Position | Ende |
---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.07.2015 |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Chairman | - |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Director/Board Member | - |
Ausbildung von Samarth Kulkarni
University of Washington | Doctorate Degree |
Indian Institute of Technology New Delhi | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
CENTESSA PHARMACEUTICALS PLC | Health Technology |
Private Unternehmen | 6 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Repare Therapeutics, Inc. | |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The private company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Commercial Services |